Report Detail

Pharma & Healthcare Global (United States, European Union and China) Erectile Dysfunction Drugs Market Research Report 2019-2025

  • RnM3682223
  • |
  • 19 August, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
North America held the largest share of the global erectile dysfunction drugs market in 2017. The U.S. is the largest pharmaceutical market in the world, and accounts for about 94% of the market in North America. The erectile dysfunction drugs market in the U.S. is driven by the availability of recognized branded formulations such as Viagra (sildenafil citrate), Cialis (tadalafil), and Levitra/Staxyn (vardenafil). However, the looming patent expiries of these branded drugs in the near future are expected to slightly alter this scenario by the end of the forecast period.
In 2019, the market size of Erectile Dysfunction Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Erectile Dysfunction Drugs.

This report studies the global market size of Erectile Dysfunction Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Erectile Dysfunction Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Apricus Biosciences Inc.
Cristalia Produtos Quimicos Farmaceuticos Ltd.
Bayer AG
Dong-A Pharmaceutical Co. Ltd.
Meda Pharmaceuticals, Inc.
Eli Lilly and Company
Pfizer, Inc.
S.K. Chemicals Co. Ltd.
Vivus, Inc.

Market Segment by Product Type
Viagra (sildenafil citrate)
Cialis (tadalafil)
Levitra/Staxyn (vardenafil)
Stendra/Spedra (avanafil)
Zydena (udenafil)
Vitaros (Alprostadil Cream)
Others

Market Segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Erectile Dysfunction Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Erectile Dysfunction Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Erectile Dysfunction Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Viagra (sildenafil citrate)
      • 1.3.3 Cialis (tadalafil)
      • 1.3.4 Levitra/Staxyn (vardenafil)
      • 1.3.5 Stendra/Spedra (avanafil)
      • 1.3.6 Zydena (udenafil)
      • 1.3.7 Vitaros (Alprostadil Cream)
      • 1.3.8 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Erectile Dysfunction Drugs Market Share by Application (2019-2025)
      • 1.4.2 Hospital Pharmacies
      • 1.4.3 Private Clinics
      • 1.4.4 Drug Stores
      • 1.4.5 Retail Pharmacies
      • 1.4.6 E-Commerce
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Erectile Dysfunction Drugs Market Size
      • 2.1.1 Global Erectile Dysfunction Drugs Revenue 2014-2025
      • 2.1.2 Global Erectile Dysfunction Drugs Sales 2014-2025
    • 2.2 Erectile Dysfunction Drugs Growth Rate by Regions
      • 2.2.1 Global Erectile Dysfunction Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Erectile Dysfunction Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Erectile Dysfunction Drugs Sales by Manufacturers
      • 3.1.1 Erectile Dysfunction Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Erectile Dysfunction Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Erectile Dysfunction Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Erectile Dysfunction Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Erectile Dysfunction Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Erectile Dysfunction Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Erectile Dysfunction Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Erectile Dysfunction Drugs Market
    • 3.6 Key Manufacturers Erectile Dysfunction Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Viagra (sildenafil citrate) Sales and Revenue (2014-2019)
      • 4.1.2 Cialis (tadalafil) Sales and Revenue (2014-2019)
      • 4.1.3 Levitra/Staxyn (vardenafil) Sales and Revenue (2014-2019)
      • 4.1.4 Stendra/Spedra (avanafil) Sales and Revenue (2014-2019)
      • 4.1.5 Zydena (udenafil) Sales and Revenue (2014-2019)
      • 4.1.6 Vitaros (Alprostadil Cream) Sales and Revenue (2014-2019)
      • 4.1.7 Others Sales and Revenue (2014-2019)
    • 4.2 Global Erectile Dysfunction Drugs Sales Market Share by Type
    • 4.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type
    • 4.4 Erectile Dysfunction Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Erectile Dysfunction Drugs Sales by Application

    6 United States

    • 6.1 United States Erectile Dysfunction Drugs Breakdown Data by Company
    • 6.2 United States Erectile Dysfunction Drugs Breakdown Data by Type
    • 6.3 United States Erectile Dysfunction Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Erectile Dysfunction Drugs Breakdown Data by Company
    • 7.2 European Union Erectile Dysfunction Drugs Breakdown Data by Type
    • 7.3 European Union Erectile Dysfunction Drugs Breakdown Data by Application

    8 China

    • 8.1 China Erectile Dysfunction Drugs Breakdown Data by Company
    • 8.2 China Erectile Dysfunction Drugs Breakdown Data by Type
    • 8.3 China Erectile Dysfunction Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Erectile Dysfunction Drugs Breakdown Data by Company
    • 9.2 Rest of World Erectile Dysfunction Drugs Breakdown Data by Type
    • 9.3 Rest of World Erectile Dysfunction Drugs Breakdown Data by Application
    • 9.4 Rest of World Erectile Dysfunction Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Erectile Dysfunction Drugs Sales by Countries
      • 9.4.2 Rest of World Erectile Dysfunction Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Apricus Biosciences Inc.
      • 10.1.1 Apricus Biosciences Inc. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
      • 10.1.4 Erectile Dysfunction Drugs Product Introduction
      • 10.1.5 Apricus Biosciences Inc. Recent Development
    • 10.2 Cristalia Produtos Quimicos Farmaceuticos Ltd.
      • 10.2.1 Cristalia Produtos Quimicos Farmaceuticos Ltd. Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
      • 10.2.4 Erectile Dysfunction Drugs Product Introduction
      • 10.2.5 Cristalia Produtos Quimicos Farmaceuticos Ltd. Recent Development
    • 10.3 Bayer AG
      • 10.3.1 Bayer AG Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
      • 10.3.4 Erectile Dysfunction Drugs Product Introduction
      • 10.3.5 Bayer AG Recent Development
    • 10.4 Dong-A Pharmaceutical Co. Ltd.
      • 10.4.1 Dong-A Pharmaceutical Co. Ltd. Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
      • 10.4.4 Erectile Dysfunction Drugs Product Introduction
      • 10.4.5 Dong-A Pharmaceutical Co. Ltd. Recent Development
    • 10.5 Meda Pharmaceuticals, Inc.
      • 10.5.1 Meda Pharmaceuticals, Inc. Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
      • 10.5.4 Erectile Dysfunction Drugs Product Introduction
      • 10.5.5 Meda Pharmaceuticals, Inc. Recent Development
    • 10.6 Eli Lilly and Company
      • 10.6.1 Eli Lilly and Company Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
      • 10.6.4 Erectile Dysfunction Drugs Product Introduction
      • 10.6.5 Eli Lilly and Company Recent Development
    • 10.7 Pfizer, Inc.
      • 10.7.1 Pfizer, Inc. Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
      • 10.7.4 Erectile Dysfunction Drugs Product Introduction
      • 10.7.5 Pfizer, Inc. Recent Development
    • 10.8 S.K. Chemicals Co. Ltd.
      • 10.8.1 S.K. Chemicals Co. Ltd. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
      • 10.8.4 Erectile Dysfunction Drugs Product Introduction
      • 10.8.5 S.K. Chemicals Co. Ltd. Recent Development
    • 10.9 Vivus, Inc.
      • 10.9.1 Vivus, Inc. Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
      • 10.9.4 Erectile Dysfunction Drugs Product Introduction
      • 10.9.5 Vivus, Inc. Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Erectile Dysfunction Drugs Sales Channels
      • 11.2.2 Erectile Dysfunction Drugs Distributors
    • 11.3 Erectile Dysfunction Drugs Customers

    12 Market Forecast

    • 12.1 Global Erectile Dysfunction Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Erectile Dysfunction Drugs Sales Forecast by Type
    • 12.3 Global Erectile Dysfunction Drugs Sales Forecast by Application
    • 12.4 Erectile Dysfunction Drugs Forecast by Regions
      • 12.4.1 Global Erectile Dysfunction Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Erectile Dysfunction Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Erectile Dysfunction Drugs. Industry analysis & Market Report on Erectile Dysfunction Drugs is a syndicated market report, published as Global (United States, European Union and China) Erectile Dysfunction Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Erectile Dysfunction Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,568.24
      3,852.36
      5,136.48
      3,017.60
      4,526.40
      6,035.20
      515,091.20
      772,636.80
      1,030,182.40
      272,863.20
      409,294.80
      545,726.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report